| Allison Marie Mascari, MS, OTR L | |
|
8409 S Avenida Del Yaqui, Guadalupe, AZ 85283-1027 | |
| (480) 897-6202 | |
| Not Available |
| Full Name | Allison Marie Mascari |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 8409 S Avenida Del Yaqui, Guadalupe, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013096478 | NPI | - | NPPES |
| 821282 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 3002 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Allison Marie Mascari, MS, OTR L 6115 W Laredo St, Chandler, AZ 85226-1716 Ph: () - | Allison Marie Mascari, MS, OTR L 8409 S Avenida Del Yaqui, Guadalupe, AZ 85283-1027 Ph: (480) 897-6202 |
News Archive
University of Toronto Faculty of Medicine researchers have uncovered a genetic basis for fundamental differences between humans and other vertebrates that could also help explain why humans are susceptible to diseases not found in other species.
Waud Capital Partners, a leading middle-market private equity firm, today announced that it has joined with veteran healthcare executives Mike Jacoutot and Mary Ann McLaughlin to acquire Revenue Cycle Solutions, Inc.
Following the recently announced success achieved during the third round of trials at its research facility at Queen's University (Kingston Ontario, Canada) Medizone International, Inc. announces that a second patent application has been filed which in combination with its previous patent application for AsepticSure™ filed in July of 2009, affords the Company greatly enhanced protection for both the hospital version of AsepticSure™ and the government variant intended for bio-terrorism countermeasures.
A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls.
A study from researchers in Switzerland found that colonoscopy with polypectomy significantly reduces colorectal cancer incidence and colorectal cancer-related death in the general population.
› Verified 6 days ago